by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersNSE Products, Inc. DBA Nu Skin Enterprises, Inc.

All Warning Letters

NSE Products, Inc. DBA Nu Skin Enterprises, Inc.

Warning LetterOpen

NSE Products, Inc. DBA Nu Skin Enterprises, Inc., 75 West Center Street Provo , UT 84601 United StatesIssued Mar 2, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations3

Issue DateMar 2, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: NSE Products, Inc. DBA Nu Skin Enterprises, Inc.
Location: NSE Products, Inc. DBA Nu Skin Enterprises, Inc., 75 West Center Street Provo , UT 84601 United States
FEI Number: N/A
Country: United States
Issue Date: March 02, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Electronic Drug Registration and Listing System (eDRLS)/Violations

NSE Products, Inc. DBA Nu Skin Enterprises, Inc. FDA Warning Letter, March 2, 2026